This provides a good overview of how Purdue accelerated opiate marketing: https://www.newyorker.com/news/news-desk/the-sackler-familys-plan-to-keep-its-billions

This provides a good overview of how Purdue accelerated opiate marketing: https://www.newyorker.com/news/news-desk/the-sackler-familys-plan-to-keep-its-billions https://www.newyorker.com/news/news-desk/the-sackler-familys... > A recent study, by a team of economists from the Wharton School, Notre Dame, and rand, reviewed overdose statistics in five states where Purdue opted, because of local regulations, to concentrate fewer resources in promoting its drug. The scholars found that, in those states, overdose rates—even from heroin and fentanyl—are markedly lower than in states where Purdue did the full marketing push. The study concludes that “the introduction and marketing of OxyContin explain a substantial share of overdose deaths over the last two decades.”